BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38805917)

  • 1. Evaluation of immunogenicity and protective efficacy of outer membrane vesicles from Salmonella Typhimurium and Salmonella Choleraesuis.
    Tian Y; Huang S; Zhou G; Fei X; Li YA; Li Q; Wang S; Shi H
    Vet Microbiol; 2024 Jul; 294():110131. PubMed ID: 38805917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outer membrane vesicles from flagellin-deficient Salmonella enterica serovar Typhimurium induce cross-reactive immunity and provide cross-protection against heterologous Salmonella challenge.
    Liu Q; Liu Q; Yi J; Liang K; Hu B; Zhang X; Curtiss R; Kong Q
    Sci Rep; 2016 Oct; 6():34776. PubMed ID: 27698383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flagellin-deficient outer membrane vesicles as adjuvant induce cross-protection of Salmonella Typhimurium outer membrane proteins against infection by heterologous Salmonella serotypes.
    Liu Q; Tan K; Yuan J; Song K; Li R; Huang X; Liu Q
    Int J Med Microbiol; 2018 Oct; 308(7):796-802. PubMed ID: 29970302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outer membrane vesicles derived from Salmonella Typhimurium mutants with truncated LPS induce cross-protective immune responses against infection of Salmonella enterica serovars in the mouse model.
    Liu Q; Liu Q; Yi J; Liang K; Liu T; Roland KL; Jiang Y; Kong Q
    Int J Med Microbiol; 2016 Dec; 306(8):697-706. PubMed ID: 27578609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salmonella Choleraesuis outer membrane vesicles: Proteomics and immunogenicity.
    Liu Q; Yi J; Liang K; Zhang X; Liu Q
    J Basic Microbiol; 2017 Oct; 57(10):852-861. PubMed ID: 28745825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outer membrane vesicles from genetically engineered
    Liu Q; Shang Y; Shen L; Yu X; Cao Y; Zeng L; Zhang H; Rao Z; Li Y; Tao Z; Liu Z; Huang X
    Virulence; 2024 Dec; 15(1):2367783. PubMed ID: 38937901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulated delayed synthesis of lipopolysaccharide and enterobacterial common antigen of Salmonella Typhimurium enhances immunogenicity and cross-protective efficacy against heterologous Salmonella challenge.
    Huang C; Liu Q; Luo Y; Li P; Liu Q; Kong Q
    Vaccine; 2016 Aug; 34(36):4285-92. PubMed ID: 27423383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multi-immunogenic outer membrane vesicles derived from an MsbB-deficient Salmonella enterica serovar typhimurium mutant.
    Lee SR; Kim SH; Jeong KJ; Kim KS; Kim YH; Kim SJ; Kim E; Kim JW; Chang KT
    J Microbiol Biotechnol; 2009 Oct; 19(10):1271-9. PubMed ID: 19884791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacterial Outer Membrane Vesicle-Mediated Cytosolic Delivery of Flagellin Triggers Host NLRC4 Canonical Inflammasome Signaling.
    Yang J; Hwang I; Lee E; Shin SJ; Lee EJ; Rhee JH; Yu JW
    Front Immunol; 2020; 11():581165. PubMed ID: 33312172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of host immune responses by oral vaccination to Salmonella enterica serovar Typhimurium harboring both FliC and FljB flagella.
    Eom JS; Seok Kim J; Im Jang J; Kim BH; Young Yoo S; Hyeon Choi J; Bang IS; Lee IS; Keun Park Y
    PLoS One; 2013; 8(9):e74850. PubMed ID: 24069357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salmonella flagellin is not a dominant protective antigen in oral immunization with attenuated live vaccine strains.
    Kodama C; Matsui H
    Infect Immun; 2004 Apr; 72(4):2449-51. PubMed ID: 15039380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Refined live attenuated Salmonella enterica serovar Typhimurium and Enteritidis vaccines mediate homologous and heterologous serogroup protection in mice.
    Tennant SM; Schmidlein P; Simon R; Pasetti MF; Galen JE; Levine MM
    Infect Immun; 2015 Dec; 83(12):4504-12. PubMed ID: 26351285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subcutaneous vaccination with attenuated Salmonella enterica serovar Choleraesuis C500 expressing recombinant filamentous hemagglutinin and pertactin antigens protects mice against fatal infections with both S. enterica serovar Choleraesuis and Bordetella bronchiseptica.
    Zhao Z; Xue Y; Wu B; Tang X; Hu R; Xu Y; Guo A; Chen H
    Infect Immun; 2008 May; 76(5):2157-63. PubMed ID: 18268026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity and Cross-Protective Efficacy Induced by Outer Membrane Proteins from Salmonella Typhimurium Mutants with Truncated LPS in Mice.
    Liu Q; Liu Q; Zhao X; Liu T; Yi J; Liang K; Kong Q
    Int J Mol Sci; 2016 Mar; 17(3):416. PubMed ID: 27011167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical evaluation of OMVs as potential vaccine candidates against
    Jiang X; Chu C; Wang Z; Gu J; Hong Y; Li Q; Jiao X
    Front Cell Infect Microbiol; 2022; 12():1037607. PubMed ID: 36389161
    [No Abstract]   [Full Text] [Related]  

  • 16. Outer Membrane Vesicles Derived from
    Tian H; Li B; Xu T; Yu H; Chen J; Yu H; Li S; Zeng L; Huang X; Liu Q
    Appl Environ Microbiol; 2021 Sep; 87(19):e0096821. PubMed ID: 34319809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Salmonella enterica serovar Typhimurium TTSS-2 deficient fur mutant as safe live-attenuated vaccine candidate for immunocompromised mice.
    Vishwakarma V; Pati NB; Chandel HS; Sahoo SS; Saha B; Suar M
    PLoS One; 2012; 7(12):e52043. PubMed ID: 23284865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engineering and preclinical evaluation of attenuated nontyphoidal Salmonella strains serving as live oral vaccines and as reagent strains.
    Tennant SM; Wang JY; Galen JE; Simon R; Pasetti MF; Gat O; Levine MM
    Infect Immun; 2011 Oct; 79(10):4175-85. PubMed ID: 21807911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of an outer membrane protein of Salmonella enterica serovar Typhimurium as a potential vaccine candidate for Salmonellosis in mice.
    Yang Y; Wan C; Xu H; Aguilar ZP; Tan Q; Xu F; Lai W; Xiong Y; Wei H
    Microbes Infect; 2013 May; 15(5):388-98. PubMed ID: 23485513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salmonella enterica serovar enteritidis core O polysaccharide conjugated to H:g,m flagellin as a candidate vaccine for protection against invasive infection with S. enteritidis.
    Simon R; Tennant SM; Wang JY; Schmidlein PJ; Lees A; Ernst RK; Pasetti MF; Galen JE; Levine MM
    Infect Immun; 2011 Oct; 79(10):4240-9. PubMed ID: 21807909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.